Oncology Institute (TOIIW) Non-Current Debt (2020 - 2026)

Oncology Institute (TOIIW) has reported Non-Current Debt for 6 consecutive years, with $78.6 million the latest figure, recorded in Q1 2026.

• Non-Current Debt for Q1 2026 came in at $78.6 million, up 6.38% year-over-year; the trailing twelve-month figure through Mar 2026 was $78.6 million (up 6.38% YoY), and the FY2025 annual result was $77.4 million, down 16.89% from the prior year.
• Non-Current Debt was $78.6 million for Q1 2026 at Oncology Institute, up from $77.4 million in the prior quarter.
• Over five years, Non-Current Debt peaked at $93.1 million in Q4 2024 and troughed at $73.9 million in Q1 2025.
• Average Non-Current Debt over 5 years is $82.8 million, with a median of $82.1 million recorded in 2023.
• Year-over-year, Non-Current Debt climbed 7.82% in 2023 and retreated 16.89% in 2025.
• Over 5 years, Non-Current Debt stood at $80.6 million in 2022, then increased by 7.7% to $86.8 million in 2023, then grew by 7.26% to $93.1 million in 2024, then declined by 16.89% to $77.4 million in 2025, then increased by 1.56% to $78.6 million in 2026.
• Per Business Quant data, the three most recent Non-Current Debt figures were $78.6 million in Q1 2026, $77.4 million in Q4 2025, and $76.2 million in Q3 2025.